Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial
Diaz, Rafael, Li, Qian H, Bhatt, Deepak L, Bittner, Vera A, Baccara-Dinet, Marie T, Goodman, Shaun G, Jukema, J Wouter, Kimura, Takeshi, Parkhomenko, Alexander, Pordy, Robert, Reiner, Željko, Roe, MaJournal:
European Journal of Preventive Cardiology
DOI:
10.1177/2047487320941987
Date:
July, 2020
File:
PDF, 423 KB
2020
File converter
More search results
More benefits 
